Helm GA - Search Results

1

Morphologic analysis of BMP-9 gene therapy-induced osteogenesis.

Varady P, Li JZ, Cunningham M, Beres EJ, Das S, Engh J, Alden TD, Pittman DD, Kerns KM, Kallmes DF, Helm GA. Varady P, et al. Among authors: helm ga. Hum Gene Ther. 2001 Apr 10;12(6):697-710. doi: 10.1089/104303401300057423. Hum Gene Ther. 2001. PMID: 11426468

2

Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy.

Alden TD, Pittman DD, Beres EJ, Hankins GR, Kallmes DF, Wisotsky BM, Kerns KM, Helm GA. Alden TD, et al. Among authors: helm ga. J Neurosurg. 1999 Jan;90(1 Suppl):109-14. doi: 10.3171/spi.1999.90.1.0109. J Neurosurg. 1999. PMID: 10413134

3

In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector.

Alden TD, Pittman DD, Hankins GR, Beres EJ, Engh JA, Das S, Hudson SB, Kerns KM, Kallmes DF, Helm GA. Alden TD, et al. Among authors: helm ga. Hum Gene Ther. 1999 Sep 1;10(13):2245-53. doi: 10.1089/10430349950017220. Hum Gene Ther. 1999. PMID: 10498255

4

Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent.

Helm GA, Alden TD, Beres EJ, Hudson SB, Das S, Engh JA, Pittman DD, Kerns KM, Kallmes DF. Helm GA, et al. J Neurosurg. 2000 Apr;92(2 Suppl):191-6. doi: 10.3171/spi.2000.92.2.0191. J Neurosurg. 2000. PMID: 10763690

5

Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery: a review.

Helm GA, Alden TD, Sheehan JP, Kallmes D. Helm GA, et al. Neurosurgery. 2000 May;46(5):1213-22. doi: 10.1097/00006123-200005000-00038. Neurosurgery. 2000. PMID: 10807254 Review.

6

The use of bone morphogenetic protein gene therapy in craniofacial bone repair.

Alden TD, Beres EJ, Laurent JS, Engh JA, Das S, London SD, Jane JA Jr, Hudson SB, Helm GA. Alden TD, et al. Among authors: helm ga. J Craniofac Surg. 2000 Jan;11(1):24-30. doi: 10.1097/00001665-200011010-00005. J Craniofac Surg. 2000. PMID: 11314095

7

A light and electron microscopic study of ectopic tendon and ligament formation induced by bone morphogenetic protein-13 adenoviral gene therapy.

Helm GA, Li JZ, Alden TD, Hudson SB, Beres EJ, Cunningham M, Mikkelsen MM, Pittman DD, Kerns KM, Kallmes DF. Helm GA, et al. J Neurosurg. 2001 Aug;95(2):298-307. doi: 10.3171/jns.2001.95.2.0298. J Neurosurg. 2001. PMID: 11780901

8

Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat.

Li JZ, Li H, Sasaki T, Holman D, Beres B, Dumont RJ, Pittman DD, Hankins GR, Helm GA. Li JZ, et al. Among authors: helm ga. Gene Ther. 2003 Sep;10(20):1735-43. doi: 10.1038/sj.gt.3302075. Gene Ther. 2003. PMID: 12939640

9

Local immunomodulation with CD4 and CD8 antibodies, but not cyclosporine A, improves osteogenesis induced by ADhBMP9 gene therapy.

Li JZ, Li H, Hankins GR, Dunford B, Helm GA. Li JZ, et al. Among authors: helm ga. Gene Ther. 2005 Aug;12(16):1235-41. doi: 10.1038/sj.gt.3302502. Gene Ther. 2005. PMID: 16034461

10

CT and radionuclide study of BMP-2 gene therapy-induced bone formation.

Varady P, Li JZ, Alden TD, Kallmes DF, Williams MB, Helm GA. Varady P, et al. Among authors: helm ga. Acad Radiol. 2002 Jun;9(6):632-7. doi: 10.1016/s1076-6332(03)80307-0. Acad Radiol. 2002. PMID: 12061736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters